We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Slower Loan Growth Hurt Capital One (COF) Q1 Earnings?
Read MoreHide Full Article
Capital One Financial Corporation (COF - Free Report) is scheduled to report first-quarter 2017 results on Apr 25, after the market closes.
Last quarter, a fall in non-interest income, an increase in provisions and rising expenses led Capital One to lag the Zacks Consensus Estimate. However, higher net interest income and easing margin pressure supported the results to some extent.
This disappointing performance along with uncertainty related to policy changes as promised by Donald Trump led to a decline in the company’s stock. For the three-months ended Mar 31, 2017, Capital One’s shares fell 2.5%.
Moreover, for the first quarter, the stock witness two downward revisions in earnings estimates (versus no upward revision), over the last 30 days. Further, the company doesn’t have an impressive earnings surprise history, as evident from the chart below:
Capital One Financial Corporation Price and EPS Surprise
Our quantitative model does not predict an earnings beat. Here is what our model indicates:
Chances of Capital One beating the Zacks Consensus Estimate in the first quarter are quite low. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #3 (Hold) or better for this to happen. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks ESP: The Earnings ESP for Capital One is -7.25%. This is because the Most Accurate estimate of $1.79 is below the Zacks Consensus Estimate of $1.93.
Zacks Rank: Capital One’s Zacks Rank #3 increases the predictive power of the ESP. However, we need to have a positive ESP to be sure of an earnings beat.
Factors to Impact Q1 Results
Slowdown in Loan Growth Should Hurt Revenues: Significant slowdown in auto, cards and commercial loans during the quarter must have led to a fall in Capital One’s net interest income (NII). Nonetheless, higher interest rates and synergies from the acquisition of GE Capital’s healthcare finance operation should have supported NII to some extent.
Expenses to Remain Stable: With the completion of the branch network optimization plan, Capital One should record a fall in operating expenses during the quarter. However, an increase in marketing expenses is expected. Hence, expenses must have been relatively stable during the first quarter.
Lower Credit Costs Likely to Support Results: Provision for credit losses are likely to remain stable or decline marginally for Capital One as the loan growth slowed down during the quarter.
Stocks that Warrant a Look
Here are a few finance stocks you may want to consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:
Zions Bancorporation (ZION - Free Report) has an Earnings ESP of +1.85% and carries a Zacks Rank #3. The company is also slated to release results on Apr 24.
Lazard Ltd (LAZ - Free Report) is scheduled to release results on Apr 27. It has an Earnings ESP of +6.41% and carries a Zacks Rank #2.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Will Slower Loan Growth Hurt Capital One (COF) Q1 Earnings?
Capital One Financial Corporation (COF - Free Report) is scheduled to report first-quarter 2017 results on Apr 25, after the market closes.
Last quarter, a fall in non-interest income, an increase in provisions and rising expenses led Capital One to lag the Zacks Consensus Estimate. However, higher net interest income and easing margin pressure supported the results to some extent.
This disappointing performance along with uncertainty related to policy changes as promised by Donald Trump led to a decline in the company’s stock. For the three-months ended Mar 31, 2017, Capital One’s shares fell 2.5%.
Moreover, for the first quarter, the stock witness two downward revisions in earnings estimates (versus no upward revision), over the last 30 days. Further, the company doesn’t have an impressive earnings surprise history, as evident from the chart below:
Capital One Financial Corporation Price and EPS Surprise
Capital One Financial Corporation Price and EPS Surprise | Capital One Financial Corporation Quote
Earnings Whispers
Our quantitative model does not predict an earnings beat. Here is what our model indicates:
Chances of Capital One beating the Zacks Consensus Estimate in the first quarter are quite low. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #3 (Hold) or better for this to happen. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks ESP: The Earnings ESP for Capital One is -7.25%. This is because the Most Accurate estimate of $1.79 is below the Zacks Consensus Estimate of $1.93.
Zacks Rank: Capital One’s Zacks Rank #3 increases the predictive power of the ESP. However, we need to have a positive ESP to be sure of an earnings beat.
Factors to Impact Q1 Results
Slowdown in Loan Growth Should Hurt Revenues: Significant slowdown in auto, cards and commercial loans during the quarter must have led to a fall in Capital One’s net interest income (NII). Nonetheless, higher interest rates and synergies from the acquisition of GE Capital’s healthcare finance operation should have supported NII to some extent.
Expenses to Remain Stable: With the completion of the branch network optimization plan, Capital One should record a fall in operating expenses during the quarter. However, an increase in marketing expenses is expected. Hence, expenses must have been relatively stable during the first quarter.
Lower Credit Costs Likely to Support Results: Provision for credit losses are likely to remain stable or decline marginally for Capital One as the loan growth slowed down during the quarter.
Stocks that Warrant a Look
Here are a few finance stocks you may want to consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:
Ameriprise Financial, Inc. (AMP - Free Report) is scheduled to release results on Apr 24. It has an Earnings ESP of +0.40% and carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zions Bancorporation (ZION - Free Report) has an Earnings ESP of +1.85% and carries a Zacks Rank #3. The company is also slated to release results on Apr 24.
Lazard Ltd (LAZ - Free Report) is scheduled to release results on Apr 27. It has an Earnings ESP of +6.41% and carries a Zacks Rank #2.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>